进展性脑血栓应用低分子肝素钙联合小剂量尿激酶的效果观察  

Effect of Low Molecular Heparin Calcium and Low Dose Urokinase in Treatment of Progressive Cerebral

作　　者：朱姝[1] 

机构地区：[1]河南省永城市人民医院神经内科,476600

出　　处：《中国继续医学教育》2015年第28期151-152,共2页China Continuing Medical Education

摘　　要：目的分析进展性脑血栓应用低分子肝素钙联合小剂量尿激酶的效果。方法回顾性的选择2014年5月~2015年5月本院收治90例进展性脑血栓患者临床资料,根据治疗时所采用不同治疗方案分为两组,对照组40例患者行低分子肝素钙治疗,研究组50例患者在其基础上行小剂量尿激酶治疗,比较两组临床疗效及治疗后神经功能缺损情况。结果研究组总有效率96.00%高于对照组45.00%,且研究组治疗后神经功能缺损评分低于对照组,比较差异具有统计学意义（P〈0.05）。结论进展性脑血栓应用低分子肝素钙联合小剂量尿激酶的效果显著。Objective Analysis of the progress of cerebral low molecular weight heparin calcium and low dose urokinase results.Methods Retrospective Selection May 2014 to May 2015 our hospital 90 cases of clinical data of patients with progressive cerebral thrombosis,according to the treatment of the different treatment options are divided into two groups,a control group of 40 patients received low molecular weight heparin therapy study group of 50 patients based on the uplink in its small dose urokinase,compare clinical efficacy and after treatment neurological deficit situation.Results Study group,the total efficiency of 96.00% was significantly higher than 45.00%,and the study group after treatment of neurological deficit scores were significantly lower than the control group,the difference was statistically significant（P〈0.05）.Conclusion Progressive cerebral low molecular weight heparin calcium and low dose urokinase effect is remarkable.

关 键 词：进展性脑血栓 低分子肝素钙 小剂量尿激酶 

分 类 号：R743.32[医药卫生—神经病学与精神病学]